Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Recruitment status changed from Recruiting to Completed on 2026-03-13, indicating enrollment has finished.
    Difference
    0.3%
    Check dated 2026-03-15T03:55:49.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T20:05:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Recruitment status changed from Recruiting to Completed and enrollment updated to 235, with the page revision noted as v3.4.2 on 2026-02-13.
    Difference
    0.4%
    Check dated 2026-02-14T13:23:50.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous v3.4.0. No substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T08:34:46.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Related topics such as 'Bladder cancer' and 'MedlinePlus Genetics' were removed from the page, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-31T05:54:46.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Expanded study overview and design details (Parts 1–4, RP2D determination and expansion, IR-NMIBC CR assessment) and updated status (Active, not recruiting), with a longer total duration (approximately 7 years 4 months).
    Difference
    2%
    Check dated 2026-01-24T04:43:32.000Z thumbnail image

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.